Home / Filing changes / CNC
Free · no account · quoted from the filing
What changed in CNC's 10-Q
Source: 10-Q filed 2026-04-28 · compared against 10-Q 2025-10-29. Every passage below is quoted verbatim from the filing itself.
Divestitures
This filing
the Company recorded impairment charges associated with the pending divestiture totaling $513 million, or $389 million after-tax
Liquidity
This filing
The maximum outstanding purchase amount permitted under the agreement is $4,250 million
Medical Cost Trend
This filing
We continue to observe and respond to elevated medical cost trend impacting the industry in recent years
Marketplace
This filing
we are operating in an evolving regulatory and market landscape that has contributed to overall market contraction and shifts in member metal tier distribution across carriers
Regulatory
This filing
The OBBBA, passed in July 2025, includes requirements that may reduce the number of members eligible for state Medicaid Expansion programs
Legal
This filing
Rosenbaum v. London, et. al, (filed January 30, 2026) in the District of Delaware
What it means — the analyst reading
The passages above are the company's own words. The plain-English reading of them — what changed, why it matters, and the direction of travel — is part of the Filing Change Monitor.
See the Filing Change Monitor →Compared from narrative excerpts (outlook, risks, MD&A) of both filings — quotes are verbatim from the new filing. Not advice. Source: company SEC filings via stockportfolio.pro. Educational, not investment advice.